HopeStage
Back to all studies
CompletedNCT00167362

Cognitive enhancement therapy for early-stage schizophrenia

About this titleRead the official source — NCT00167362
Behavioural studyAges 16–51United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 16 years to 51 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 2001
Recruitment status
Completed
Enrollment listed in the registry
67
Sponsor
Beth Israel Deaconess Medical Center
Sponsor type
Hospital / academic medical center
Study type
Behavioral
Intervention type
Behavioural
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
From 16 Years to 51 Years
Official registry ID
NCT00167362
Official title
Show the full official title

Rehabilitation, Brain Function and Early Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Beth Israel Deaconess Medical Center, a hospital or academic medical center.

Who was this study for?

Listed age limits: 16 years to 51 years.

Want to explore more studies?

Explore studies